Fritz Bach

Q: What Schools Are Affiliated With Fritz Bach

Fritz Bach is affiliated with the following schools: University of Minnesota, University of Michigan, University of Wisconsin–Madison, Keele University, Harvard University

Fritz Bach's AcademicInfluence.com Rankings

Fritz Bach

Biology

#2931

World Rank

#4566

Historical Rank

#1251

USA Rank

Immunology

#120

World Rank

#127

Historical Rank

#40

USA Rank

biology Degrees

Download Badge

Biology

Why Is Fritz Bach Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Fritz Heinz Bach was an Austrian-born American transplant physician and immunobiologist. He was considered one of the pioneers in the field of transplant immunology. Being born in a Jewish family in Vienna, Bach fled Nazism at an early age. He was moved to England in the Kindertransport, and later with his family made the journey overseas to the United States. He obtained a scholarship to study at Harvard and continued his studies until graduating in 1960. Soon afterwards, Bach made his first contributions to the field of transplant immunology. One of his main achievements was the development of the mixed lymphocyte culture test, which furthered research on preventing transplant rejection. Bach spent the main part of his career at University of Wisconsin–Madison, University of Minnesota and Harvard Medical School. He retired in 2006.

(See a Problem?)

Fritz Bach's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway (2000) (2032)
Heme oxygenase-1: unleashing the protective properties of heme. (2003) (1175)
Carbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell Apoptosis (2000) (999)
Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. (1968) (781)
Identification and Characterization of CD39/Vascular ATP Diphosphohydrolase* (1996) (556)
Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury (2003) (535)
Transplantation of discordant xenografts: a review of progress. (1990) (531)
One-Way Stimulation in Mixed Leukocyte Cultures (1966) (488)
Carbon Monoxide Generated by Heme Oxygenase-1 Suppresses the Rejection of Mouse-to-Rat Cardiac Transplants1 (2001) (481)
DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells (1991) (467)
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. (1997) (463)
Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. (1991) (459)
Accommodation of vascularized xenografts: Expression of “protective genes” by donor endothelial cells in a host Th2 cytokine environment (1997) (447)
Differential function of major histocompatibility complex antigens in T-lymphocyte activation (1976) (392)
Detection of a novel human class II HLA antigen (1983) (375)
HISTOCOMPATIBILITY MATCHING VI. MINIATURIZATION OF THE MIXED LEUKOCYTE CULTURE TEST: A PRELIMINARY REPORT (1971) (341)
Heme Oxygenase-1 Modulates the Expression of Adhesion Molecules Associated with Endothelial Cell Activation1 (2004) (321)
Cytokine‐inducible expression in endothelial cells of an I kappa B alpha‐like gene is regulated by NF kappa B. (1993) (320)
Immune Response and Mitosis of Human Peripheral Blood Lymphocytes in vitro (1963) (319)
Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. (1994) (295)
Loss of ATP Diphosphohydrolase Activity with Endothelial Cell Activation (1997) (291)
SEROLOGICALLY DEFINED AND LYMPHOCYTE-DEFINED COMPONENTS OF THE MAJOR HISTOCOMPATIBILITY COMPLEX IN THE MOUSE (1972) (290)
Heme Oxygenase-1-derived Carbon Monoxide Requires the Activation of Transcription Factor NF-κB to Protect Endothelial Cells from Tumor Necrosis Factor-α-mediated Apoptosis* (2002) (284)
The molecular basis of alloreactivity. (1990) (283)
Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection (1990) (277)
A20 Blocks Endothelial Cell Activation through a NF-κB-dependent Mechanism* (1996) (271)
Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. (2001) (269)
The Major Histocompatibility Complex — Genetics and Biology (1976) (266)
Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. (1991) (265)
Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. (1992) (260)
Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B (1996) (258)
Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. (1980) (248)
Bilirubin: A Natural Inhibitor of Vascular Smooth Muscle Cell Proliferation (2005) (247)
Barriers to xenotransplantation (1995) (245)
Protection Against Ischemia/Reperfusion Injury in Cardiac and Renal Transplantation with Carbon Monoxide, Biliverdin and Both (2005) (235)
Protective genes expressed in endothelial cells: a regulatory response to injury. (1997) (231)
PHENOTYPIC EXPRESSIONS OF THE MAJOR HISTOCOMPATIBILITY LOCUS IN MAN (HL-A): LEUKOCYTE ANTIGENS AND MIXED LEUKOCYTE CULTURE REACTIVITY (1968) (229)
A20 Inhibits Cytokine-Induced Apoptosis and Nuclear Factor κB–Dependent Gene Activation in Islets (1999) (229)
CELL-MEDIATED LYMPHOLYSIS IMPORTANCE OF SEROLOGICALLY DEFINED H-2 REGIONS (1973) (228)
Heme oxygenase-1: from biology to therapeutic potential. (2009) (226)
Cell Mediated Immunity: Separation of Cells Involved in Recognitive and Destructive Phases (1973) (215)
Heavy chain ferritin acts as an anti‐apoptotic gene that protects livers from ischemia‐reperfusion injury (2003) (212)
HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytes. (1975) (211)
Endothelial Cell Activation and Thromboregulation during Xenograft Rejection (1994) (210)
Carbon Monoxide Protects against Liver Failure through Nitric Oxide–induced Heme Oxygenase 1 (2003) (208)
Uncertainty in xenotransplantation: Individual benefit versus collective risk (1998) (205)
Hypoxia-inducible factor 1α stabilization by carbon monoxide results in cytoprotective preconditioning (2007) (197)
The barrier to xenotransplantation. (1991) (196)
Heme oxygenase‐1‐derived carbon monoxide protects hearts from transplant‐associated ischemia reperfusion injury (2004) (196)
Glucocorticoid-mediated Repression of NFκB Activity in Endothelial Cells Does Not Involve Induction of IκBα Synthesis* (1996) (195)
Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts (2004) (194)
Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts (1990) (189)
IN-VITRO STUDIES OF LYMPHOCYTES FROM PATIENTS WITH SARCOIDOSIS AND LYMPHOPROLIFERATIVE DISEASES. (1964) (187)
Precipitation of radioactively labeled samples: a semi-automatic multiple-sample processor. (1972) (184)
Biliverdin therapy protects rat livers from ischemia and reperfusion injury (2004) (179)
Lymphocyte reactivity in vitro. I. Cellular reconstitution of purified lymphocyte response. (1970) (177)
Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta. (1987) (175)
Regulation of the Tissue Factor Promoter in Endothelial Cells (1995) (173)
Hu-1: Major Histocompatibility Locus in Man (1967) (170)
A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. (1998) (170)
Biliverdin protects the functional integrity of a transplanted syngeneic small bowel. (2004) (163)
Five HLA-D clusters associated with HLA-DR4. (1982) (160)
Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity (1979) (159)
Endothelial cell antigens recognized by xenoreactive human natural antibodies. (1990) (159)
Direct activation of porcine endothelial cells by human natural killer cells. (1996) (157)
T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection. (1996) (154)
Carbon monoxide orchestrates a protective response through PPARgamma. (2006) (146)
THE ROLE OF NATURAL ANTIBODIES IN THE ACTIVATION OF XENOGENIC ENDOTHELIAL CELLS (1991) (146)
A miniaturized mouse mixed leukocyte culture in serum-free and mouse serum supplemented media. (1973) (145)
Accommodation: a working paradigm for progressing toward clinical discordant xenografting. (1991) (144)
Human T lymphocyte clones reactive in primed lymphocyte typing and cytotoxicity (1979) (144)
Genetic and Immunological Complexity of Major Histocompatibility Regions (1972) (141)
Modulation of endothelial cell apoptosis by heme oxygenase-1-derived carbon monoxide. (2002) (139)
Antigen-driven helper cell-independent cloned cytolytic T lymphocytes (1981) (136)
Inhibition of NF-κB by Pyrrolidine Dithiocarbamate Blocks Endothelial Cell Activation (1995) (135)
Lymphocyte reactivity in vitro. II. Soluble reconstituting factor permitting response of purified lymphocyte. (1970) (133)
The role of C5a and antibody in the release of heparan sulfate from endothelial cells (1991) (130)
Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. (1998) (129)
Therapeutic applications of bilirubin and biliverdin in transplantation. (2007) (128)
Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. (2002) (124)
Interferon: a cytotoxic T lymphocyte differentiation signal (1986) (122)
Heme oxygenase‐1: a therapeutic amplification funnel (2005) (121)
Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors. (1997) (119)
Heme Oxygenase-1 Mediates the Anti-Inflammatory Effects of Acute Alcohol on IL-10 Induction Involving p38 MAPK Activation in Monocytes (2006) (119)
An Elsia Assay For Xenoreactive Natural Antiboides (1990) (113)
Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation. (2002) (113)
Heme oxygenase‐1 is essential for and promotes tolerance to transplanted organs (2006) (112)
Continuous culture of T cells cytotoxic for autologous human leukaemia cells (1979) (112)
Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs (2004) (112)
Modification of vascular responses in xenotransplantation: Inflammation and apoptosis (1997) (112)
Xenogeneic endothelial cells activate human prothrombin. (1997) (111)
Lymphocyte reactivity to serologically undetected components of the major histocompatibility complex. (1973) (108)
Heme oxygenase‐1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells (2007) (107)
Polymorphism of human Ia antigens generated by reciprocal intergenic exchange between two DR β loci (1986) (105)
The HLA class II genes and products: the HLA-D region. (1985) (102)
Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. (2004) (101)
Thrombin activates nuclear factor-kappaB and potentiates endothelial cell activation by TNF. (1997) (101)
Heme oxygenase‐1 modulates the allo‐immune response by promoting activation‐induced cell death of T cells (2005) (100)
Immunomodulatory effects of inhaled carbon monoxide on rat syngeneic small bowel graft motility (2003) (99)
Cellular basis of the proliferative response of human T cells to mouse xenoantigens (1990) (99)
Cell Surface Biliverdin Reductase Mediates Biliverdin-induced Anti-inflammatory Effects via Phosphatidylinositol 3-Kinase and Akt* (2009) (97)
Heme Oxygenase‐1‐Generated Biliverdin Ameliorates Experimental Murine Colitis (2005) (97)
Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation. (1998) (96)
NK-kappa B subunit-specific regulation of the I kappa B alpha promoter. (1994) (95)
Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis. (1998) (94)
Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells (1978) (94)
Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells (1976) (93)
Antigenic Requirements for Triggering of Cytotoxic T Lymphocytes (1977) (93)
Cytotoxicity: Specificity after in vitro Sensitization (1970) (92)
Bilirubin and Biliverdin Treatment of Atherosclerotic Diseases (2007) (91)
Bilirubin Inhibits Tumor Cell Growth via Activation of ERK (2007) (91)
The involvement of LD- and SD-region differences in MLC and CML: a three-cell experiment. (1973) (90)
Heme Oxygenase-1 Protects Pancreatic β Cells From Apoptosis Caused by Various Stimuli (2001) (90)
Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B. (1997) (90)
Apyrase administration prolongs discordant xenograft survival. (1996) (89)
SB: a new HLA-linked human histocompatibility gene defined using HLA-mutant cell lines (1981) (89)
Role of endothelial cells in transplantation. (1995) (88)
Carbon monoxide pretreatment prevents respiratory derangement and ameliorates hyperacute endotoxic shock in pigs (2005) (88)
Donor treatment with carbon monoxide can yield islet allograft survival and tolerance. (2005) (88)
Factors in Xenograft Rejection (1999) (86)
Neutrophil adhesion to xenogeneic endothelium via iC3b. (1991) (86)
GENETIC CONTROL OF CELL-MEDIATED LYMPHOLYSIS IN MOUSE (1974) (85)
Current concepts: immunology. Transplantation immunology. (1987) (84)
Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection. (1998) (83)
Heme oxygenase‐1, a protective gene that prevents the rejection of transplanted organs (2001) (83)
T cell clones (1981) (82)
Bilirubin can induce tolerance to islet allografts. (2006) (77)
Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts. (1999) (75)
Arachidonic Acid Influences Proinflammatory Gene Induction by Stabilizing the Inhibitor-κBα/Nuclear Factor-κB (NF-κB) Complex, thus Suppressing the Nuclear Translocation of NF-κB* (1997) (75)
Signal requirements in the step-wise functional maturation of cytotoxic T lymphocytes (1987) (74)
Lysis of leukemia cells by spleen cells of normal mice. (1975) (74)
Toll‐like receptor 4 suppression leads to islet allograft survival (2007) (74)
Specificity of Allogeneic Cell Recognition by Human Lymphocytes in vitro (1971) (74)
Human monocytes activate porcine endothelial cells, resulting in increased E-selectin, interleukin-8, monocyte chemotactic protein-1, and plasminogen activator inhibitor-type-1 expression. (1997) (74)
Dw/LD-related molecular polymorphism of DR4 β-chains (1983) (73)
Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB. (1999) (72)
Use of HLA loss mutants to analyse the structure of the human major histocompatibility complex (1982) (72)
QUANTITATIVE ASSAY OF ANTIGENIC DISPARITY AT HL-A—THE MAJOR HISTOCOMPATIBILITY LOCUS IN MAN (1968) (69)
Insulin-dependent diabetes--associated HLA-D region encoded determinants. (1985) (68)
Inhibition of platelet integrin GPIIbIIIa prolongs survival of discordant cardiac xenografts. (1996) (68)
Cessation of immunosuppression after renal transplantation. (1976) (68)
ALLOGENEIC AND XENOGENEIC RESPONSE IN MIXED LEUKOCYTE CULTURES (1972) (68)
Potentiation of in vitro Lymphocyte Reactivity (1970) (67)
The major histocompatibility complex in transplantation immunology. (1973) (67)
Xenotransplantation: problems and prospects. (1998) (66)
"Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases", summary of the ERS Research Seminar in Budapest, Hungary, September, 1999. (2001) (66)
POLYREACTIVITY AND ANTIGEN SPECIFICITY OF HUMAN XENOREACTIVE MONOCLONAL AND SERUM NATURAL ANTIBODIES (1991) (65)
Bilirubin Promotes De Novo Generation of T Regulatory Cells (2010) (65)
Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. (1996) (64)
Specificity of Antigen Recognition by Human Lymphocytes in vitro (1970) (64)
A multigene family on human chromosome 12 encodes natural killer-cell lectins (2004) (63)
Call for moratorium on xenotransplants (1998) (63)
RECOMBINANT ADENOVIRAL MEDIATED CD39 GENE TRANSFER PROLONGS CARDIAC XENOGRAFT SURVIVAL1 (2000) (63)
Regulation of murine splenocyte responses by heparan sulfate. (1991) (63)
Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets. (1989) (62)
Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival. (1996) (61)
Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome (1969) (61)
Genetic and cellular aspects of xenogeneic mixed leukocyte culture reaction (1976) (60)
Lymphocyte studies in congenital thymic dysplasia: The one-way stimulation test. (1968) (57)
Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with infiltration by mononuclear cells secreting interferon-gamma and diffuse endothelial activation. (1993) (57)
Heme oxygenase-1 as a protective gene. (2002) (57)
Thymic transplantation in a case of chronic mucocutaneous candidiasis. (1971) (57)
TREATMENT OF SEVERE COMBINED IMMUNODEFICIENCY WITH BONE-MARROW FROM AN UNRELATED, MIXED-LEUCOCYTE-CULTURE-NONREACTIVE DONOR (1975) (57)
Immunology of xenograft rejection. (1990) (56)
CELL KINETIC STUDIES IN MIXED LEUKOCYTE CULTURES: AN in vitro MODEL OF HOMOGRAFT REACTIVITY (1969) (56)
Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes. (1988) (55)
Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity. (1989) (55)
Mechanism of cultured endothelial injury induced by lymphokine-activated killer cells. (1988) (55)
Overexpression of A1, an NF-kappaB-inducible anti-apoptotic bcl gene, inhibits endothelial cell activation. (1999) (54)
In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts. (1994) (54)
Mitogenic action of phytohaemagglutinin. (1963) (53)
Human lymphocytes recognise mouse alloantigens (1975) (52)
Characterization of a novel gene (NKG7) on human chromosome 19 that is expressed in natural killer cells and T cells. (1993) (52)
HLA associations with leukemia (1987) (52)
Evidence that 15-deoxyspergualin inhibits natural antibody production but fails to prevent hyperacute rejection in a discordant xenograft model. (1992) (52)
Heme oxygenase-1 in organ transplantation. (2007) (51)
Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection. (1996) (51)
Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells. (1980) (51)
Leukemia-Associated Antigens in the Mixed Leukocyte Culture Test (1969) (50)
Histocompatibility and isoenzyme differences in commercially supplied "BALB/c" mice. (1982) (50)
IMMUNE RESPONSE AND MITOSIS OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN VITRO. (1964) (50)
Human xenoreactive natural antibodies of the IgM isotype activate pig endothelial cells (1994) (49)
25th anniversary of the first successful allogeneic bone marrow transplants. (1994) (49)
A study of HLA-DR2 associated HLA-Dw/LD specificities. (1984) (49)
Detection of HLA restricted anti-minor histocompatibility antigen(s) reactive cells from skin GVHD lesions. (1984) (48)
Isolation and characterization of NK cell or NK/T cell-specific cDNA clones. (1990) (48)
THE IN VITRO IMMUNE RESPONSE OF PERIPHERAL BLOOD LYMPHOCYTES. (1965) (48)
OKT4+ cytotoxic T cells can lyse targets via class I molecules and can be blocked by monoclonal antibody against T4 molecules. (1984) (47)
Cross-Regulation of Carbon Monoxide and the Adenosine A2a Receptor in Macrophages (2007) (47)
Helper cell-independent cytolytic T lymphocytes specific for a minor histocompatibility antigen. (1983) (47)
HLA C ASSOCIATIONS WITH ACUTE LEUKAEMIA (1984) (47)
Expression of human thrombomodulin cofactor activity in porcine endothelial cells. (1998) (47)
Mixed leukocyte culture studies in families with known HL-A genotypes. (1969) (46)
Heme oxygenase-1 end-products carbon monoxide and biliverdin ameliorate murine collagen induced arthritis. (2012) (46)
Comparison of in vivo and in vitro immune response to purified hepatocytes. (1990) (46)
Removal of IgM anti-endothelial antibodies results in prolonged cardiac xenograft survival. (1990) (45)
Helper cell-independent cytotoxic clones in man (1982) (45)
Human xenoreactive natural antibodies--avidity and targets on porcine endothelial cells. (1993) (45)
Modulation of Nucleotide Triphosphate Diphosphohydrolase-1 (NTPDase-1)/cd39 in Xenograft Rejection (1999) (44)
An ELISA assay for xenoreactive natural antibodies. (1990) (44)
Cloned Cytotoxic and Non‐Cytotoxic Lymphocytes in Mouse and Man: Their Reactivities and a Large Cell Surface Membrane Protein (LMP) Differentiation Marker System (1981) (44)
Genetic heterogeneity of diabetes and HLA (1982) (43)
Mixed lymphocyte culture reactivity and H-2 histocompatibility loci differences. (1972) (43)
Alternative pathways of T lymphocyte activation (1978) (43)
Recognitive specificity of human cytotoxic T lymphocytes. I. Antigen- specific inhibition of human cell-mediated lympholysis (1975) (42)
Transient complement inhibition plus T-cell immunosuppression induces long-term survival of mouse-to-rat cardiac xenografts. (1998) (42)
In vivo depletion of xenoreactive natural antibodies with an anti-mu monoclonal antibody. (1993) (42)
ROLE OF H-2 LYMPHOCYTE-DEFINED AND SEROLOGICALLY-DEFINED COMPONENTS IN THE GENERATION OF CYTOTOXIC LYMPHOCYTES (1974) (42)
Discordant xenografting: challenges and controversies. (1991) (42)
EVIDENCE THAT POLYREACTIVE ANTIBODIES ARE DEPOSITED IN REJECTED DISCORDANT XENOGRAFTS (1993) (41)
Analysis of cloned T cell function. II. Differential blockade of various cloned T cell functions by cyclosporine. (1983) (40)
Biliverdin protects rat livers from ischemia/reperfusion injury. (2003) (40)
SUPPRESSION OF SYNTHESIS OF NATURAL ANTIBODIES BY MYCOPHENOLATE MOFETIL (RS‐61443): ITS POTENTIAL USE IN DISCORDANT XENOGRAFTING (1993) (40)
Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin. (1997) (40)
T and B lymphocytes: recognition and function (1979) (39)
Selective suppression of endothelial cell activation by arachidonic acid (1996) (39)
Barriers to xenotransplantation. (1999) (39)
Secondary cell-mediated lympholysis: importance of H-2 LD and SD factors (1976) (39)
H-2 antigen class: effect on mouse islet allograft rejection. (1983) (39)
Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival. (1993) (38)
Association of Mouse Major Histocompatibility and Rauscher Murine Leukaemia Virus Envelope Glycoprotein Antigens on Leukaemia Cells and their Recognition by Syngeneic Virus‐Immune‐Cytotoxic T‐Lymphocytes (1978) (38)
Survival of accommodated cardiac xenografts upon retransplantation into cyclosporine-treated recipients. (1998) (38)
Regulation of Monocyte Tissue Factor Activity by Allogeneic and Xenogeneic Endothelial Cells (1998) (38)
Specificity of Cell‐Mediated Lympholysis for Public and Private H‐2 Determinants (1975) (38)
Southern analysis of DNA polymorphism among Dw subtypes of DR4. (1985) (38)
Prolonged survival of xenografts after organ culture. (1977) (37)
EVIDENCE FOR DIRECT AND INDIRECT PATHWAYS IN THE GENERATION OF THE ALLOIMMUNE RESPONSE AGAINST PANCREATIC ISLETS (1991) (37)
In vitro elimination of specific immunoreactive cells with 5-bromodeoxyuridine. (1971) (36)
Hu-1: Major histocompatibility locus in man. (1967) (36)
Secondary Responses of Human Lymphocytes to Alloantigens In Vitro (1975) (35)
A cDNA clone expressed in natural killer and T cells that likely encodes a secreted protein (1990) (35)
Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines (1978) (35)
Cell-mediated immunity: differential maturation of mixed leukocyte reaction and cell-mediated lympholysis (1975) (35)
Rejection of cardiac xenografts by CD4+ or CD8+ T cells. (1999) (35)
Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck. (1992) (34)
Heme oxygenase-1 and transplantation tolerance. (2006) (34)
Depletion of human NK cells with monoclonal antibodies allows the generation of cytotoxic T lymphocytes without NK-like cells in mixed cultures. (1983) (34)
Recombinant interferon alpha can induce rearrangement of T-cell antigen receptor alpha-chain genes and maturation to cytotoxicity in T-lymphocyte clones in vitro. (1986) (34)
HLA class II restriction of T helper cell response to cytomegalovirus (CMV). I. Immunogenetic control of restriction. (1987) (34)
cDNA cloning and sequencing reveals that the electrophoretically constant DR beta 2 molecules, as well as the variable DR beta 1 molecules, from HLA-DR2 subtypes have different amino acid sequences including a hypervariable region for a functionally important epitope. (1987) (34)
Induction of xenograft accommodation by modulation of elicited antibody responses12 (2002) (34)
Potential mechanism of abnormal thromboregulation in xenograft rejection: loss of ecto-ATPases upon endothelial cell activation. (1996) (33)
Role of sendai virus fusion-glycoprotein in target cell susceptibility to cytotoxic T cells (1977) (33)
PREDICTIVE VALUE OF RESULTS OF MIXED LEUKOCYTE CULTURES FOR SKIN ALLOGRAFT SURVIVAL IN MAN (1967) (33)
Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type I activation. (1998) (33)
Adenoviral-mediated overexpression of I(kappa)B(alpha) in endothelial cells inhibits natural killer cell-mediated endothelial cell activation. (1996) (33)
A new in vitro approach to determine acquired tolerance in long-term kidney allograft recipients. (1990) (32)
Clonal analysis of HLA-DR and -DQ associated determinants: their contribution to Dw specificities. (1986) (32)
T-cell-specific murine Ia antigens: serology of I-J and I-E subregion specificities (1978) (32)
Prolonged survival of a discordant cardiac xenograft in a rhesus monkey. (1991) (32)
REACTION OF COMPLEMENT WITH ENDOTHEUAL CELLS IN A MODEL OF XEN0TRANSPLANTATION (1991) (32)
Afferent and efferent pathways in T cell responses to MHC class I+, II-hepatocytes. (1989) (31)
Bone Marrow and Thymus Transplants: Cellular Engineering to Correct Primary Immunodeficiency (1974) (31)
THE RELATIONSHIP OF IN VITRO LYMPHOCYTE COMPATIBILITY TO HOMOGRAFT SENSITIVITY IN MAN * (1964) (31)
MIXED LEUKOCYTE CULTURE REACTIVITY AND CHRONIC GRAFT‐VERSUS-HOST REACTIONS (SECONDARY DISEASE) BETWEEN ALLOGENEIC H‐2k MOUSE STRAINS (1974) (31)
Selective inhibition of E‐selectin, ICAM‐1, and VCAM in endothelial cells (1994) (30)
Xenotransplantation: endothelial cell activation and beyond. (1995) (30)
Analysis of cloned T cell function. I. Dissection of cloned T cell proliferative responses using cyclosporin A. (1982) (30)
Successful transplantation of a human leukemia cell line into nude mice: conditions optimizing graft acceptance. (1982) (30)
Accommodation of xenografts: expression of "protective genes" in endothelial and smooth muscle cells. (1997) (30)
Phorbol myristate acetate and in vitro T lymphocyte function. I. PMA may contaminate lymphokine preparations and can interfere with interleukin bioassays. (1983) (30)
Genetic nomenclature for theH-2 complex of the mouse (1974) (29)
Mapping of lymphocyte surface polypeptide antigens by chemical cross-linking with BSOCOES. (1980) (29)
Aggregation of human platelets induced by porcine endothelial cells is dependent upon both activation of complement and thrombin generation (1996) (29)
A SENSITIVE MICROMETHOD FOR GENERATING AND ASSAYING ALLOGENEICALLY INDUCED CYTOTOXIC HUMAN LYMPHOCYTES (1976) (29)
The biosynthesis of Ly-5 in T and B cells. (1981) (28)
Structural model for T-cell recognition of HLA class II-associated alloepitopes. (1990) (28)
DNA restriction fragment length polymorphisms characteristic for Dw subtypes of DR2. (1986) (28)
Long-Term Survival of Hamster Hearts in Presensitized Rats1 (2000) (28)
Augmentation of cell number and LAK activity in peripheral blood mononuclear cells activated with anti-CD3 and interleukin-2 (1988) (27)
Chimerism detected by HL-A typing. (1973) (27)
Cloned primed-lymphocyte-test reagents in the dissection of HLA-D. (1980) (27)
Transplantation: pairing of donor and recipient. (1970) (27)
Modulation of vascular ATP diphosphohydrolase by fatty acids (1997) (27)
Generation of lymphokine-activated killer activity in T cells. Possible regulatory circuits. (1991) (26)
Cell surface changes in alloantigen activated T lymphocytes (1978) (26)
Detection of HSV-1-induced lymphokine production in human cells by a direct indicator cell addition assay. (1984) (26)
Accommodation of xenografts: A concept revisited (1995) (26)
Inhibition of NF-kappa B by pyrrolidine dithiocarbamate blocks endothelial cell activation. (1995) (26)
NKG2‐C is a receptor on human natural killer cells that recognizes structures on K562 target cells (1995) (26)
Depletion of donor Ia+ cells before transplantation does not prolong islet allograft survival. (1986) (26)
CD39/vascular ATP diphosphohydrolase modulates xenograft survival. (2000) (25)
A “Minimal Signal‐Stepwise Activation” Analysis of Functional Maturation of T Lymphocytes (1989) (25)
Response against single minor histocompatibility antigens. I. Functional and immunogenetic analysis of cloned cytolytic T cells. (1983) (25)
Accommodation — The Role of Natural Antibody and Complement in Discordant Xenograft Rejection (1991) (25)
Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level. (1984) (25)
DR2+ haplotypes in insulin-dependent diabetes: analysis of DNA restriction fragment length polymorphisms. (1986) (25)
CELL-MEDIATED LYMPHOLYSIS (1973) (25)
Adenovirus-mediated gene transfer of A20 renders endothelial cells resistant to activation: a means of evaluating the role of endothelial cell activation in xenograft rejection. (1997) (25)
Inhaled carbon monoxide prevents graft-induced intimal hyperplasia in swine. (2007) (25)
Candidate natural killer cell receptors. (1992) (24)
CD3 negative "small agranular lymphocytes" are natural killer cells. (1991) (24)
Sensitization of lymphocytes against pooled allogeneic cells. II. Characterization of effector cells cytotoxic for autologous lymphoblastoid cell lines. (1981) (24)
Hemizygous HLA mutants of lymphoblastoid cells: a new cell type for histocompatibility testing. (1980) (24)
Early detection and specificity analysis of human cytolytic T lymphocyte (CTL) colonies generated in soft agarose culture: a potential assay for definition of CTL defined (CD) determinants. (1981) (24)
Specific tolerance in human kidney allograft recipients. (1972) (24)
Molecular analysis of the immune response to human cytomegalovirus glycoprotein B (gB). II. Low gB-specific T and B cell responses are associated with expression of certain HLA-DR alleles. (1994) (24)
Molecular relationships between large membrane proteins (LMP) expressed on T and B lymphocytes. (1980) (23)
Stepwise activation of T cells. Role of the calcium ionophore A23187. (1987) (23)
Genetic Control of Mixed Leukocyte Culture Reactivity (1972) (23)
Dissociation in expression of MB1/MT1 and DR1 alloantigens in mutants of a lymphoblastoid cell line. (1983) (23)
Genetic mapping of H-2 LD loci. (1973) (23)
Collaboration between in vivo responses to LD and SD antigens of major histocompatibility complex (1976) (23)
POOL-PRIMING: A MEANS OF GENERATING T LYMPHOCYTES CYTOTOXIC TO TUMOUR OR VIRUS-INFECTED CELLS (1978) (23)
Cartilage-hair hypoplasia: Effect of thymus transplants (1972) (23)
HLA associations with leukemia. (1987) (22)
Adenovirus-mediated gene transfer of the anti-apoptotic protein A20 in rodent islets inhibits IL-1 beta-induced NO release. (1999) (22)
High-level expression of functional human thrombomodulin in cultured porcine aortic endothelial cells. (1995) (22)
Depletion of IgM Xenoreactive Natural Antibodies by Injection of anti‐μ Monoclonal Antibodies (1994) (22)
Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. II. In vitro-generated "memory" cells to class I+ class II- hepatocytes. (1992) (22)
The cellular mechanism of maintenance of neonatally induced tolerance to H-2 class I antigens. (1983) (22)
Clonal analysis of T lymphocyte response to an isolated class I disparity. (1983) (22)
Cloned cellular reagents to define antigens encoded between HLA-DR and glyoxylase. (1982) (22)
Mixed leukocyte cultures and immune response region disparity. (1973) (21)
Xenotransplantation: A current perspective (1992) (21)
Gem, a GTP-binding protein from mitogen-stimulated T cells, is induced in endothelial cells upon activation by inflammatory cytokines. (1997) (21)
LYMPHOCYTE REACTIVITY IN VITRO: VII. The Effect Of Polymorphonuclear Leukocytes On Lymphocyte Response (1971) (21)
Cell kinetic studies in mixed leukocyte cultures: an in vitro model of homograft reactivity. (1970) (21)
I-N: a newly described H-2 I subregion between K and I-A (1980) (21)
Suppression of delayed xenograft rejection by specific depletion of elicited antibodies of the IgM isotype. (1999) (21)
The major histocompatibility complex (HLA) as a genetic marker in human craniofacial anomalies. (2008) (21)
Genomic structure of NKG5, a human NK and T cell-specific activation gene (2004) (21)
Molecular analysis of the immune response to human cytomegalovirus glycoprotein B. I. Mapping of HLA-restricted helper T cell epitopes on gp93. (1993) (21)
Comparison of mitomycin C and X-irradiation as blocking agents in one-way mixed leucocyte cultures. (1972) (20)
Adenovirus-mediated gene transfer of A20 in murine islets inhibits Fas-induced apoptosis. (2001) (20)
Carbon Monoxide Protects Pancreatic -Cells From Apoptosis and Improves Islet Function/Survival After (2002) (20)
Immunobiology and therapeutic applications of protein c/protein s/thrombomodulin in human and experimental allotransplantation and xenotransplantation. (1997) (20)
Long-term survival after bone marrow transplantation: a 15-year follow-up report of a patient with Wiskott-Aldrich syndrome. (1984) (20)
Xenotransplantation: a view to the future. (1993) (20)
Inhibition of Endothelial Cell Activation by -Mediated Expression of IκBα, an Inhibitor of the Transcription Factor NF-κB (1998) (19)
A novel function for A20 in smooth muscle cells: inhibition of activation and proliferation. (1999) (19)
Regulated and endothelial cell-specific expression of Fas ligand: an in vitro model for a strategy aiming at inhibiting xenograft rejection. (1998) (19)
Phorbol ester mediates reversible reduction of cloned T lymphocyte cytolysis. (1983) (19)
Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA. (1990) (19)
Activation of T cells by H-2 factors in the graft-vs-host reaction. (1973) (19)
Membrane-associated lymphotoxin on natural killer cells activates endothelial cells via an NF-kappaB-dependent pathway. (1998) (19)
Revisiting a challenge in transplantation: discordant xenografting. (1991) (18)
The stepwise activation of cytotoxic T lymphocytes. (1987) (18)
Speculations on Alternative Pathways of T‐ Lymphocyte Response (1979) (18)
Effect of cyclosporin A on murine and human T helper cell clones. (1982) (18)
HLA class II typing by restriction fragment length polymorphism (RFLP) in unrelated bone marrow transplant patients. (1989) (18)
Dw/LD associated molecular polymorphism of DR4 beta-chains: intramolecular localization of polymorphic sites. (1983) (17)
A shrewd and ethical approach to xenotransplantation. (2002) (17)
Overexpression of A1, an NF-κB–Inducible Anti-Apoptotic Bcl Gene, Inhibits Endothelial Cell Activation (1999) (17)
POOLED STIMULATING CELLS AS A “STANDARD STIMULATOR” IN MIXED LYMPHOCYTE CULTURE (1976) (17)
Cellular basis of anti-SB response. (1984) (17)
Transplantation: Problems of Histocompatability Testing Typing and matching tests are useful in pairing donors and recipients for organ transplantation (1968) (17)
Cell subsets responding to purified hepatocytes and evidence of indirect recognition of hepatocyte major histocompatibility complex class I antigen. I. The role of L3T4+ T cells in the development of allospecific cytotoxicity in hepatocyte-sponge matrix allografts. (1992) (17)
Cell-mediated autoimmunity in type I diabetes. (1987) (17)
Xenotransplantation: problems posed by endothelial cell activation. (1994) (17)
Natural killer lectin-like receptors have divergent carboxyl-termini, distinct from C-type lectins (2004) (17)
Histocompatibility matching. V. A comparison of typing and mixed cultures in unrelated individuals. (2008) (16)
Evolutionary and genetic implications of sequence variation in two nonallelic HLA-DR beta-chain cDNA sequences. (1987) (16)
Primed LD Typing: Reagent Preparation and Definition of the HLA‐D‐Region Antigens (1977) (16)
Genetics of transplantation: the major histocompatibility complex. (1976) (16)
Alloantigen-activated CML suppression independent of cytotoxic activity. (1979) (16)
Protective genes expressed in endothelial cells of second hamster heart transplants to rats carrying an accommodated first graft (1996) (16)
a-GALACTOSYL EPITOPE-MEDIATED ACTIVATION OF PORCINE AORTIC ENDOTHELIAL CELLS (1998) (15)
HLA and disease--the perils of simplification. (1990) (15)
Mechanisms of Delayed Xenograft Rejection (1997) (15)
Lack of donor-specific tolerance in mice with established anti-Ia-treated islet allografts. (1983) (15)
POSSIBLE ASSOCIATION BETWEEN HLA-AW24 AND METASTATIC TESTICULAR GERM-CELL TUMOURS (1979) (15)
Cellular Detection of HLA Class II-Encoded Determinants: Subtype Polymorphisms of HLA-D (1986) (15)
Soluble complement receptor type 1 and cobra venom factor in discordant xenotransplantation. (1996) (15)
Generation of Allospecific Cytolytic T-Lymphocytes Stimulated by Pure Pancreatic β-Cells in Absence of la+ Dendritic Cells (1989) (15)
Relationship of large and small CD3‐ CD56+ lymphocytes mediating NK‐associated activities (1992) (15)
The major histocompatibility complex--genetics and biology (second of three parts). (1976) (15)
In vitro sensitization of thymocytes. Role of H-21 I region determinants and cell-free mixed leukocyte culture supernates in generation of cytotoxic responses (1978) (14)
Tyrosine phosphorylation following lectin meiated endothelial cell stimulation (1998) (14)
Delayed xenograft rejection in complement-depleted T-cell-deficient rat recipients of guinea pig cardiac grafts. (1996) (14)
Measurement of natural antibody in a discordant xenograft model. (1992) (14)
Lyt phenotypes of alloreactive precursor and effector cytotoxic T lymphocytes. (1981) (14)
Specific detection of HLA-D antigens using primed LD typing (PLT). (1976) (14)
Full-length DQβ cDNA sequences of HLA-DR2/DQw1 subtypes: Genetic interactions between two DQβ loci generate human class II HLA diversity (1990) (14)
Lymphokine-activated killer (LAK) cells can be focused at sites of tumor growth by products of macrophage activation. (1987) (14)
Endothelial cell proteoglycans in xenotransplantation. (1990) (14)
Cellular immunogenetics and LD-CD collaboration. (1977) (14)
Genetic Engineering as an Approach to Xenotransplantation (1997) (14)
Inhibition of platelet GPIIbIa in an ex vivo model of hyperacute xenograft rejection does not prolong cardiac survival time (1996) (14)
Inhibition of anti-class I cytotoxicity by anti-class II monoclonal antibodies (MoAb). II. Blocking of anti-class I CTL clones by anti-DR MoAb. (1985) (14)
The H(Tla) histocompatibility locus: a study of in vitro lymphocyte reactivity. (1973) (14)
Long-term survival of hamster hearts in presensitized rats. (2001) (13)
Three HLA-D region antigens defined by primed LD typing (1976) (13)
Carbon monoxide: from the origin of life to molecular medicine. (2006) (13)
Pathways of procoagulation in discordant xenografting. (1994) (13)
Antigenic requirements for the generation of secondary cytotoxicity. (1977) (13)
Acquired donor-specific hyporesponsiveness in long-term kidney allograft recipients. (1991) (13)
Responses against single minor histocompatibility antigens. II. Analysis of cloned helper T cells. (1984) (13)
Ethical and Legal Issues in Technology: Xenotransplantation (2001) (13)
Analysis of human class II antigens by cloned cytolytic T cell reagents: a study using HLA loss mutant lymphoblastoid cell lines and monoclonal antibodies detecting the HLA-DP product(s). (1985) (13)
Endothelial and host mononuclear cell activation and cytokine expression during rejection of pig-to-baboon discordant xenografts. (1995) (13)
HLA antigens in renal cell carcinoma. (1983) (13)
The role of HLA-DR and HLA-DQ products in T lymphocyte activation and in contributing to "Dw specificities". (1986) (12)
Xenotransplantation: a view of issues. (1992) (12)
Endothelial cells in xenotransplantation: do they accommodate? (1994) (12)
Genetics of the mixed leukocyte culture response: a reexamination. (1972) (12)
HL-A antigens and mixed leukocyte culture reactivity. (1973) (12)
Specificity and structural analysis of a guinea pig transfer factor-like activity. (1977) (12)
Lymphocyte reactivity in vitro. VI. Specificity of target cell destruction following in vitro sensitization in mixed leukocyte cultures (1972) (12)
The major histocompatibility complex--genetics and biology. (First of three parts). (1976) (12)
Activation of endothelial cells in hyperacute xenograft rejection. (1992) (12)
Typing for HLA-D: primed LD typing and homozygous typing cells. (2008) (12)
Renal allograft survival in CSA-treated patients with positive donor-specific B cell crossmatches. (1989) (12)
Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells. (1980) (12)
Dw subtypes of serologically defined DR-DQ specificities restrict recognition of cytomegalovirus. (1986) (12)
Murine T cell Ia antigens. II. Further studies on an I-J subregion specificity. (1979) (11)
Determination of DR β1 alleles of DR4/Dw subtypes of oligonucleotide probing (1987) (11)
35 – Cloning of T Lymphocytes in Man (1982) (11)
Anti-B cell agents: suppression of natural antibodies and prolongation of survival in discordant xenografts. (1994) (11)
Differential Function of MHC LD and SD Determinants (1976) (11)
Lymphokine activated killer (LAK) cell-mediated endothelial injury: a mechanism for capillary leak syndrome in patients treated with LAK cells and interleukin-2. (1987) (11)
Generation of primary cytotoxic lymphocytes against non-major histocompatibility complex antigens by anti-Ia serum plus complement- treated lymphocytes (1980) (11)
Genetic engineering of endothelial cells to ameliorate xenograft rejection. (1996) (11)
Isolation of a cDNA clone encoding a novel form of granzyme B from human NK cells and mapping to chromosome 14 (1990) (11)
T-cell clonal analysis of HLA-DR2 haplotypes. (1987) (11)
HLA loss variants of a B27+ lymphoblastoid cell line: genetic and cellular characterization. (1984) (11)
Leukemia-associated antigens in the mixed leukocyte culture test. (1970) (11)
Functionally distinct human T cell clones that produce lymphokines with IL-2-like activity. (1984) (10)
The phenotype of antigen-specific suppressor T cells generated in human mixed leucocyte culture depends on the nature of the major histocompatibility regions recognized. (1984) (10)
Heme oxygenase-1 inhibition prevents intimal hyperplasia enhancing nitric oxide-dependent apoptosis of vascular smooth muscle cells. (2011) (10)
Primed LD typing (PLT)-technical considerations. (1976) (10)
The intron-exon structure of the porcine E-selectin-encoding gene. (1996) (10)
HLA CD antigen crossmatching--the pool cell-mediated lympholysis test. (1978) (10)
Expression of a truncated form of the human p55 TNF-receptor in bovine aortic endothelial cells renders them resistant to human TNF. (1996) (10)
Human alloreactive CTL clones: loss and reacquisition of specific cytolytic activity can be regulated by "recombinant" interleukin 2. (1985) (10)
Deletion analysis of the porcine E-selectin promoter. (1996) (10)
Comparison of DR β1 alleles from diabetic and normal individuals (1987) (10)
Pathogenesis of and potential therapies for delayed xenograft rejection (1999) (10)
HO-1 upregulation protects the pancreatic cell line betaTC3 from cytokines and Fas-induced apoptosis. (2001) (10)
Bone marrow transplantation. Aggravating factors in graft-versus-host disease. (1970) (10)
MLC incompatibility index for donor--recipient matching. (1977) (10)
Xenotransplantation: problems and approaches. (1994) (9)
Protein analysis of HLA-DR2.3 haplotype. (1987) (9)
DNA and Protein Studies of HLA Class II Molecules: Their Relationship to T Cell Recognition (1985) (9)
On getting a T-cell clone and being assured you have one. (1983) (9)
A comparison of the neonatal tolerance-inducing capacities of H-2 class I and class II antigens. (1983) (9)
The role of gp70 in the target antigen recognized by murine leukemia virus immune cytotoxic T‐lymphocytes (1980) (9)
Natural antibody production can be inhibited by 15-deoxyspergualin in a discordant xenograft model. (1992) (9)
Xenotransplantation. Prolonged survival of xenografts after organ culture. (1977) (9)
Blockade of p38 MAPK inhibits chronic allograft vasculopathy. (2008) (9)
RESPONSIVENESS OF GERMFREE MICE IN MIXED LEUKOCYTE CULTURE (1972) (9)
Normal histocompatibility antigens as a model for tumors. (1974) (9)
GAMMA-GLOBULIN PRODUCTION BY HUMAN LYMPHOCYTES IN VITRO. (1963) (9)
A20 expression inhibits endothelial cell activation. (1997) (9)
Tumor infiltrating lymphocytes in squamous cell carcinoma of the head and neck: mechanisms of enhancement using prostaglandin synthetase inhibitors. (1997) (9)
Direct cell contact is required to induce expression of E-selectin and IL-8 secretion in pig endothelial cells by human natural killer cells. (1996) (9)
The xenotransplantation question: public consultation is an important part of the answer. (2002) (9)
Complexity of the HLA-D region studied by primed-lymphocyte test. (1980) (9)
Cellular reactivities associated with theta-antigen disparity. (1973) (9)
Inhibition of platelet GPIIbIIIa prolongs survival of discordant cardiac xenografts. (1996) (9)
Xenotransplantation: progress toward clinical development. (1997) (8)
Studies of the mixed lymphocyte reaction by the virus plaque assay. (1975) (8)
RECOGNITION IN MLC AND CML: THE LD-SD DICHOTOMY (1975) (8)
Guinea Pig “Transfer Factor” In Vitro: Physico-Chemical Properties and Partial Purification (1976) (8)
Abrogation of cytotoxicity of mixed leukocyte cultures. (1972) (8)
H-2 I-region encoded targets in allograft rejection (1979) (8)
Cellular basis of neonatal induction of in vitro tolerance (1976) (8)
High frequency of splenic anti-class I cytotoxic T lymphocyte precursors correlates with in vivo rejection of K/D region disparate thyroid and islet grafts in mice. (1984) (8)
Role of CD2 and IL 1 beta in T cell responsiveness to IL 2. (1987) (8)
IMMUNOLOGICAL RESPONSES OF HUMAN LYMPHOCYTES IN VITRO * (1964) (8)
Expression of a negative dominant mutant of human p55 tumor necrosis factor-receptor inhibits TNF and monocyte-induced activation in porcine aortic endothelial cells. (1997) (8)
Dw/LD-RELATED MOLECULAR POLYMORPHISM (1983) (8)
Thrombin Inhibition in discordant xenograft rejection (1997) (8)
Activation of Peroxisome Proliferator-Activated Receptor γ Prolongs Islet Allograft Survival (2012) (8)
Xenotransplantation: a possible solution to the shortage of donor organs. (1996) (8)
Putting the public at risk. (1999) (8)
Primed lymphocyte typing in the assay of HLA-D region disparity. (1977) (8)
Human anti-lymphoma responses generated in vitro and in vivo following sensitization with allogeneic leukocytes (2004) (8)
DQ β sequences in HLA-DR4 haplotypes☆ (1987) (8)
Disease and the HL-A histocompatibility system. (1971) (8)
Discordant xenografting: a summary and look to the future. (1992) (7)
C1q receptors and endothelial cell activation. (1999) (7)
Xenograft accommodation is accompanied by intragraft Th2 cytokines and vascular expression of protective genes (1997) (7)
The effect of 5,8,11,14-eicosatetraynoic acid on endothelial cell gene expression. (1997) (7)
Intron-exon structure of the porcine IκBα-encoding gene (1995) (7)
Guinea pig transfer factor-like activity detected in vitro. (1975) (7)
Lymphoblastoid cell lines of homozygous typing cells used for sensitization in PLT. (2008) (7)
Long-term maintenance of "cloned" human PLT cells in TCGF with LCL cells as a feeder layer. (1980) (7)
Long-term culture of LAK cells: expansion and activation signals. (1987) (7)
The effect of mismatching for HLA-DR in recipients of renal allografts sharing one HLA-ABC haplotype with related donors. (1983) (7)
Importance of different regions of H-2 for MLC stimulation. (2008) (7)
Lyt phenotypes of responding cells in secondary alloantigen responses. (1979) (7)
The nature of cells responding in mixed leukocyte cultures and cell-mediated lympholysis. (1973) (7)
Genetic and molecular analyses of lymphocyte-defined HLA-D region specificities. (1983) (7)
Determinants not correlated with HLA-Dw, DR, or SB detected by primed lymphocyte typing. (1982) (7)
HLA-Dw/LD directed cytotoxic T cell clones. (1984) (7)
Differences in susceptibility to rejection of mouse pancreatic islet allografts disparate for class I or class II major histocompatibility antigens. (1983) (6)
Antitumor cytotoxic T cells and non-T-cells generated by allosensitization in vitro. (1980) (6)
Natural antibody targets on discordant endothelium: molecular characterization and consequences of antibody binding. (1991) (6)
Cellular recognition of major histocompatibility complex antigens. (1977) (6)
Characterisation of rat anti-guinea pig circulating xenoreactive natural antibodies and secreting cells. (1995) (6)
HLA-FA: A Non-DR, Non-DQ HLA Class II Product (1984) (6)
Danger of doctrinal tyranny in the terminology of H-2. (1973) (6)
Use of anti-mu monoclonal antibody as a therapeutic approach to achieve depletion of xenoreactive natural antibodies. (1994) (6)
Renal allograft survival in patients with positive donor-specific B lymphocyte crossmatches. (1987) (6)
Treatment of severe combined immunodeficiency by a small number of pretreated nonmatched marrow cells. (1973) (6)
Molecular Polymorphism of DR and DQ Products (1984) (6)
Phorbol myristate acetate and in vitro T lymphocyte function. II. Influence of PMA and supernatants from PMA-treated P388D1 cells on the proliferation of cloned T cells. (1983) (6)
Lymphocyte Response as a Model of Cell-Mediated Immunity (1971) (5)
Close association between the Dw14 (LD40) subtype of HLA-DR4 and a Restriction element for antigen-specific T-cell clones (2004) (5)
Genetic studies of mixed leukocyte culture reactivity in human developmental anomalies. (1973) (5)
Reconsideration of the mechanism of first-set vascularized allograft rejection: some concluding remarks. (1990) (5)
Human natural killer cells induce expression of E-selectin and interleukin-8 mRNA in porcine endothelial cells. (1996) (5)
Histocompatibility matching. VII. Mixed leukocyte cultures between chimpanzee and man. (1972) (5)
Bone marrow transplantation for aplastic anemia. Establishment of chimerism using multiple HL-A identical donors following pretreatment with cyclophosphamide. (1971) (5)
ANTIGEN SPECIFICITY AND HELPER CHARACTERISTICS OF ANTIGEN‐DRIVEN HELPER‐CELL-INDEPENDENT CYTOLYTIC T LYMPHOCYTES (1983) (5)
Differential cellular immune responsiveness to systems of the major histocompatibility complex. (1976) (5)
Atypical patterns of inheritance of the serologically detectable (SD) products of the HL-A complex in human developmental anomalies. (1973) (5)
Soluble adherent cell activity permitting purified lymphocyte response. (1971) (5)
Inhibition of anti-class I cytotoxicity by anti-class II monoclonal antibodies (MoAb). I. Blocking of bulk non-DR and non-DQ-directed cytotoxic T cells by MoAb against DR, DQ, and DP. (1985) (5)
The major histocompatibility complex - genetics and biology (third of three parts). (1976) (5)
The role of cell-surface glycoproteins in the activation of endothelial cells by antibody and complement. (1992) (5)
Deposition of polyreactive antibodies in xenograft rejection: detection using antiidiotype monoclonal antibodies. (1992) (5)
THYROID GRAFT REJECTION BETWEEN C57BL/6 AND H‐2Kb MUTANT MICE (1983) (5)
Long-term integrity of renal function in cadaver allografts. (1970) (4)
Helper cells in murine thymus for the generation of primary cytolytic T lymphocyte (CTL) responses in vitro. (1981) (4)
The growth of cells with LAK activity in an automated tissue culture system (Acusyst P). (1987) (4)
The Availability for Recognition of Normal H‐2 Antigens by Cytotoxic T Lymphocytes on a Rauscher‐Virus‐transformed Cell, RBL‐5A (1979) (4)
Adenosine nucleotides induce E-selectin expression in porcine endothelial cells. (1997) (4)
Renal Allograft Survival in Patients with Positive B Cell Crossmatch to Their Donor (1984) (4)
Past, present, and future aspects of histocompatibility. (1979) (4)
Xenotransplantation : problems for consideration (1991) (4)
Heparan sulfate augments the splenocyte response to mitogenic stimuli. (1991) (4)
Recognitive specificity of human cytotoxic T lymphocytes. II. The non-recognition of antigens controlled outside the major histocompatibility complex. (2008) (4)
Rejection of established mouse pancreatic islet allografts by active immunization requires class I (H-2 K, D) antigen disparities. (1984) (4)
Sustained suppression of xenoreactive natural antibodies: anti-IgM monoclonal antibody and anti-B cell immunosuppressants. (1994) (4)
Characterization of xenoreactive natural secreting cells in rats (1994) (4)
Xenotransplantation: a possible option for the future. (1997) (4)
Renal transplant donor selection by mixed lymphocyte culture. (1974) (4)
HLA and diabetes from a T-cell perspective. (1987) (4)
NO1: an HLA-DQw1-associated determinant present on loss mutants not expressing DQw1. (1986) (4)
H2 associated determinants analyzed with human lymphocytes [proceedings ]. (1976) (4)
Mixed leukocyte culture incompatibility index for donor-recipient selection in kidney transplantation. (1977) (4)
DISSOCIATION OF FUNCTIONAL RESPONSES OF LYMPHOCYTE SUBPOPULATIONS (1976) (4)
T-CELL-SPECIFIC MURINE Ia ANTIGENS: SEROLOGY OF I-J and I-E SUBREGION SPECIFICITIES 1 (1979) (4)
Rejection of hamster cardiac xenografts by rat CD4+ or CD8+ T cells. (1999) (4)
Predictive value of mixed leukocyte culture testing on allograft survival in unrelated dogs. (1975) (3)
Identification of a novel DR beta cDNA clone. (1988) (3)
Cytolytic T lymphocyte clones with helper-cell characteristics. (1983) (3)
Continuous infusion of recombinant interleukin-2 and lymphokine-activated killer cells in refractory malignancies. (1989) (3)
Transplantation: moving toward the 21st century. (1990) (3)
Unidirectional thyroid graft rejection between B10.S and B10.S(7R) mouse strains. (1984) (3)
Cloned human T lymphocytes in PLT analysis of the HLA-D complex. (1981) (3)
A new immunosuppressive mechanism for cyclosporin-A demonstrated with cloned T-lymphocytes. (1983) (3)
Specificity of destruction by lymphocytes activated in mixed leukocyte culture. (1972) (3)
TH2 cytokines regulate gene expression and proinflammatory responses in xenografts. (2001) (3)
Donor preconditioning with carbon monoxide (CO) in pig-to-primate xenotransplantation (2003) (3)
The current status of the major histocompatibility complex (HLA) in family studies of craniofacial developmental anomalies. (1980) (3)
Induced Heme Oxygenase-1 Upregulation Protects Pancreatic Beta Cells from Apoptosis In Vitro (2001) (3)
DL-A LD matching: its prognostic value for kidney allograft survival. (1975) (3)
Human anti-murine mixed leukocyte culture: effects of cytokines. (1991) (3)
Lymphocyte-defined differences of the major histocompatibility complex. (1972) (3)
Genetic and cellular control of in vitro models of allograft reactivity. (1975) (3)
Regulation of lytic function by recombinant IL2 and antigen. (1986) (3)
Some problems related to discordant xenografting. (1997) (3)
The Genetics of Histocompatibility (1970) (3)
Selective inhibition of E-selectin expression by alpha-globulins. (1994) (3)
Human LD antigens are present on xenogeneic cells (1977) (3)
Linkage disequilibrium or epistasis? (2008) (3)
Genetic control of histocompatibility antigens. (1973) (3)
LD sharing between species. (1977) (3)
Immunogenetic disparity and graft-versus-host reactions. (1974) (2)
Analysis of Cytolytic Clones Directed at Class I and Class II Antigens Using HLA Loss Mutants of a Lymphoblastoid Cell Line (1984) (2)
Albumin deposition in dermal capillary basement membrane in parents of Type 1 (insulin-dependent) diabetic patients (1984) (2)
Vascular ATP Diphosphohydrolase (CD39/ATPDase) (1997) (2)
Murine T Cell Ia Antigens (1979) (2)
Overexpression of A 1 , an NFk B – Inducible Anti-Apoptotic Bcl Gene , Inhibits Endothelial Cell Activation (1999) (2)
The alienation of tumor immunity: alien-driven diversity and alien-selected escape. (1980) (2)
Prolongation of skin allograft survival in lymphocyte-depleted mice. (1970) (2)
Genetic engineering of endotheiial cells (1995) (2)
Activation in Monocytes on IL-10 Induction Involving p38 MAPK Anti-Inflammatory Effects of Acute Alcohol Heme Oxygenase-1 Mediates the (2006) (2)
LACK OF TOLERANCE TO DONOR‐STRAIN SKIN GRAFTS IN MICE WITH ESTABLISHED ISLET ALLOGRAFTS1 (1987) (2)
Heme Oxygenase-1 (HO-1) (2002) (2)
GENETIC AND CELLULAR ASPECTS OF MIXED LEUKOCYTE CULTURE AND CELL MEDIATED LYMPHOLYSIS REACTIONS (1976) (2)
Transplantation: problems of histocompatibility testing. (1968) (2)
Cell mediated lympholysis: effect of papain on effector and target cells. (1973) (2)
Rejection crises that resolve can be triggered by passenger cells in otherwise syngeneic transplants. (1981) (2)
Immunobiology of discordant xenograft rejection and potential therapeutic modalities. (1996) (2)
Xenotransplantation: The Current Status of Understanding (1994) (2)
L3T4+,LyT2- and LyT2+,L3T4- T cells participate in the generation of allospecific cytotoxicity in response to MHC class I+ hepatocytes. (1989) (2)
H-2 associated determinants analyzed with human lymphocytes. Abstr. (1976) (2)
Revised mixed leukocyte culture test. (1970) (2)
Primed lymphocyte typing predicts MLC reactivity between unrelated individuals. (2008) (2)
Retinoic acid inhibits expression of E-selectin in endothelial cells and prolongs discordant xenograft survival. (1994) (2)
Histocompatibility and Transplantation. (1971) (2)
Participation of class II alloantigens in in vivo regulation of K/D region disparate thyroid graft rejection in mice. (1985) (2)
Possible relationships among HL-A histocompatibility components. (1973) (2)
Differences in cell surface phenotype of functionally disparate cloned T cells. (1981) (2)
DQ beta sequences in HLA-DR4 haplotypes. (1987) (2)
Donor recipient pairing: an attempt to reconcile its theoretical power with its practical utility. (1974) (2)
Correlation of Primary Sequence and Functional Determinants of HLA Class II Molecules (1989) (2)
RAPID COMMUNICATION A20 Inhibits NF-kB Activation in Endothelial Cells Without Sensitizing to Tumor Necrosis Factor–Mediated Apoptosis (1998) (2)
STIMULATION OF LYMPHOCYTES WITH ALLOGENEIC NORMAL CELLS AND AUTOLOGOUS LYMPHOBLASTOID CELL LINES: DISTINCTION BETWEEN NK-LIKE CELLS AND CYTOTOXIC T LYMPHOCYTES BY MONOCLONAL ANTIBODIES (1982) (2)
Transplanting porcine hearts to humans (1996) (2)
Intron-exon structure of the porcine I kappa B alpha-encoding gene. (1995) (2)
Differential recognition by thymocytes of H-2 and non-H-2 alloantigens (1974) (2)
Differential allo-response of murine thymocytes to H- 2 K region different recombinants and to H-2Kb mutants. (1980) (2)
A 50-year retrospective: cell-mediated immunity and the major histocompatibility complex. (1999) (2)
Mixed leukocyte cultures in transplantation immunology. (1971) (1)
Reply 1 to “Xenotransplantation—caution, but no moratorium” (1998) (1)
Looking back 25 years. (2004) (1)
Cell-mediated immunity: its basis and analysis. (1990) (1)
Oligonucleotide probing. Applications to HLA typing. (1988) (1)
Early Inhibition of heme oxygenase enzymatic activity precipitates xenograft rejection. (1999) (1)
Molecular Studies of a Rare HLA Haplotype: Implications for Mechanisms of Generating Class II Gene Polymorphisms (1989) (1)
Enhanced cytotoxicity of allosensitized T cells for autologous lymphoblastoid cell lines and human leukemia cells following propagation in T-cell growth factor. (1980) (1)
HLA: Its Role in Pathogenesis of Disease (1987) (1)
Protective Responses of Endothelial Cells (2000) (1)
Xenotransplantation: Hopes and Goals (2001) (1)
HO‐1 UPREGULATION PROTECTS THE PANCREATIC BETA CELL LINE &bgr; TC3 FROM CYTOKINE AND FAS‐INDUCED APOPTOSIS.: Abstract# 341 Poster Board #‐Session: P188‐I (2000) (1)
Carbon monoxide (CO) prevents apoptotic events related to ischemia/reperfusion (IR) injury in an hDAF pig-to-primate xenotransplantation model (2003) (1)
Allo-responsive T lymphocytes and their differentiation markers. (1981) (1)
The alloimmune response against pancreatic islets is generated by both direct and indirect pathways. (1991) (1)
Induction of immune skin lesions by T-lymphocyte clones of particular subclasses. (1985) (1)
Role of non-HLA antigens in primed LD typing. (1977) (1)
T Cell Specific Ia Antigens of the I-J and I-E Subregions of H-2 (1978) (1)
Inhibition of endothelial cell function: should this be a main goal of immunosuppressive strategies? (1997) (1)
Pretreatment of islets with anti-Ia monoclonal antibodies. (1985) (1)
Helper cell-independent cytotoxic T lymphocytes (HITc) in mouse and man. (1982) (1)
Lymphocyte reactivity in mixed leukocyte cultures—Its assay and genetics (1966) (1)
Frequency of W4 and W6 antigens in perennial, nonallergic asthmatics. (1977) (1)
Assay of HLA-D disparity. (1977) (1)
The endothelial cell: an obstacle to xenografting. (1994) (1)
Antigen-specific lymphoblastoid cell lines: possible methods for establishment and potential application in systems of delayed hypersensitivity. (1973) (1)
Factors in discordant xenograft survival (1999) (1)
Matching-typing complementarity in histocompatibility testing. (1971) (1)
HLA Mutants of Lymphoblastoid Cell Lines: Generation of New Mutants and Analysis by Southern Blotting (1984) (1)
Mixed Leukocyte Culture and Cell-Mediated Lympholysis Assays: Models of Allograft Rejection (1973) (1)
Isolation of Human NK Cell and NK/T Cell Specific cDNA Clones (1989) (1)
HLA and susceptibility to type I diabetes. Hypothesis. (1982) (1)
Role of Endothelial Cells in Transplantation (Part 2 of 2) (1995) (1)
Immunogenetic considerations in islet transplantation: The role of Ia antigens in graft rejection (1984) (1)
The role of genetics in autoimmune disease. (1991) (1)
Brief Det~nitive Report Dw/ld-related Molecular Polymorphism of Dr4 Fl-chains* (2003) (1)
BILIRUBIN SUPPRESSES NEOINTIMA FORMATION BY INTERACTING WITH THE RETINOBLASTOMA TUMOR SUPPRESSOR PROTEIN PATHWAY (2004) (1)
Prediction of renal allograft rejection by direct lymphocyte blastogenesis assay. (1977) (1)
Transplantation: Pairing of Donor and Recipient (1970) (1)
Phenotypic expression in T-lymphocyte x "fibroblast" cell hybrids. (1978) (1)
Cellular basis of response to k-region class i mhc disparities. (1983) (1)
Localization of the human mitogen-induced GTP-binding protein gem to chromosome 8q22.3. (1996) (1)
IN VITRO MODELS OF Hh-MEDIATED RESISTANCE AND MHC INCOMPATIBILITY (1978) (1)
Minimal signals and step-wise maturation of cytotoxic T cells. (1988) (1)
Problems Relating to the Transplantation of Discordant Xenografts (1991) (1)
Histocompatibility genetics and immunosuppression. (1969) (1)
Lymphokine-activated Killer Activity in Long-Term Cultures with Anti-CD 3 plus Interleukin 2 : Identification and Isolation of Effector Subsets 1 (2006) (1)
HLA-D: The T Cell Perspective (1985) (0)
Identification of Products Encoded by NK Cell-Derived cDNA Clones (1990) (0)
Full-length DQ beta cDNA sequences of HLA-DR2/DQw1 subtypes: genetic interactions between two DQ beta loci generate human class II HLA diversity. (1990) (0)
Immnogenetics and cellular basis of long-term renal graft acceptance in patients with total lymphoid irradiation (1988) (0)
Alien histocompatibility antigens and alloimmunization: conceptual and practical considerations. (1981) (0)
[Xenotransplantation: current status and future prospects]. (2003) (0)
Xenograft Rejection Major Component in the Pathogenesis of Complement-Fixing Elicited Antibodies Are a (2017) (0)
Genetic studies of cell-surface determinants in human developmental anomalies--a preliminary report. (1973) (0)
Long term culture of lymphokine activated killer lak cells activation with okt3 il1 and interferon (1987) (0)
CONSIDERATIONS FOR EVALUATION OF FACTORS AFFECTING CYTOTOXIC T‐LYMPHOCYTE DIFFERENTIATION * (1979) (0)
PLT investigation of a new HLA-D cluster (1980) (0)
Therapeutic effects of inhaled carbon monoxide on endotoxic shock-induced lung injury in pig. (2005) (0)
Immunogenetics of tissue grafting (1982) (0)
T cell recognized polymorphism associated with HLA-DR2 haplotypes. (1987) (0)
Therapie genique utile lors de transplantations et contre les inflammations ou les thromboses (1996) (0)
2.2-06 Indirect response to allogeneic peptides (1989) (0)
Bilirubin suppresses neointima formation by inhibition of vascular smooth muscle cell proliferation (2004) (0)
Bilirubin : a natural inhibitor of arteriosclerosis(The 105th Annual Congress of Japan Surgical Society) (2005) (0)
ORGAN PRETREATMENT WITH BILIRUBIN PROTECTS FROM CARDIAC ISCHEMIA REPERFUSION INJURY (2006) (0)
Mouse-to-Rat Cardiac Transplants Oxygenase-1 Suppresses the Rejection of Carbon Monoxide Generated by Heme (2001) (0)
Carbon monoxide improves the results of tissue and organ transplantation and suppresses adoptosis. (2002) (0)
Sequence of a DQ beta clone from the DRw 15-Dw 22 cell line REM. (1990) (0)
Elicitation of T-lymphocyte responses by major histocompatibility complex encoded determinants. (1984) (0)
Naive Xenografts Complement That Precipitate Rejection of Presence of Anti-Donor Antibodies and Accommodated Xenografts Survive in the (1999) (0)
Graft rejection in donor-recipient pairs with differing of H-2 loci. (1979) (0)
Antigenic regulation of cytotoxic t cell activity in mice neonatally tolerized to h-2. Abstr. (1982) (0)
A Schema for Immunotherapy1 (1973) (0)
CARBON MONOXIDE PREVENTS REJECTION OF CARDIAC ALLOGRAFTS VIA ACTIVATION OF HIF1A;: 1455 (2008) (0)
Collaborating T and B cells (1975) (0)
Molecular polymorphism of hla dr and hla dq products (1984) (0)
Immunobiology of transplantation : the histocompatability systems (1974) (0)
Immunogenetics of HLA. (1991) (0)
Comparison of SACRAH and M-SACRAH in patients with rheumatoid arthritis and osteoarthritis (2019) (0)
Influence of donor HO-1 polymorphism genotype on late kidney transplantation outcome (2007) (0)
Xenotransplantation of discordant, immediately-vascularized organs. (1993) (0)
Donor-recipient pairing for MHC LD and CD determinants. (1978) (0)
Delayed Xenograft Rejection is Initiated by Elicited Igm Anti-graft Antibodies. (1999) (0)
Bilirubin and Biliverdin Di-Taurate for the Treatment of Renal Ischemia Reperfusion Injury: 2269 (2008) (0)
HLA and susceptibility to type I diabetes (2008) (0)
Approaches to the evaluation of histocompatibility antigens (1974) (0)
T lymphocyte subpopulations responsive to alloantigens. (1979) (0)
Histocompatibility genes in man. (1969) (0)
A schema for immunotherapy. (1973) (0)
Th2 cells/cytokines promote the long-term survival of hamster hearts in rats. (1999) (0)
A 50-year retrospective: cell-mediated immunity and the major histocompatibility complex. (2002) (0)
PRIMED LD TYPING: ANALYSIS OF THE HLA-D COMPLEX (1977) (0)
The D locus (LD) antigens of the HLA complex (1976) (0)
D. Bernard Amos: humanist, scientist and friend. (1997) (0)
T LYMPHOCYTE REACTIVITIES TO ALLO- AND ALTERED-SELF ANTIGENS (1979) (0)
Hyperacute rejection of discordant guinea pig to rat liver xenografts is mediated by global complement activation (1995) (0)
B cell positive crossmatches and renal allograft survival (1988) (0)
LEUCOCYTE CULTURE METHODOLOGY: Production and Assay of Soluble Factors (1971) (0)
Presensitized Rats Long-Term Survival of Hamster Hearts in (2000) (0)
Lysis of syngeneic mouse tumor cells by effector cells generated in vitro following stimulation with allogeneic normal cells. Abstr. (1980) (0)
Expression and analysis of membrane phenomena associated with major histocompatibility genes. (1975) (0)
Optimizing selection of unrelated donors for successful bone marrow transplantation (1988) (0)
Evolutionary and genetic implications of sequence variation in two nonallelic HLA-DR 13-chain cDNA sequences ( HLA class II antigens / genetic polymorphism / DNA sequence homology ) (0)
apoptosis and organ transplantation and suppresses (2002) (0)
Immunogenetic complexity of HLA-D. (1977) (0)
SHORT COMMUNICATION Mixed Lymphocyte Culture Reactivity and H-2 Histocompatibility Loci Diff erencesl" (1972) (0)
CELL SURFACE INTERACTIONS IN MIXED LEUKOCYTE CULTURES (1972) (0)
Apoptosis Endothelial Cells Without Sensitizing to Inhibits Proinflammatory Gene Expression in Dominant Negative Mutant of p 65 / RelA Adenovirus-Mediated Expression of a and (1998) (0)
Subject Index, Vol. 106, 1995 (1995) (0)
A method for producing a reagent for determination of human leukocyte antigens and its application (1977) (0)
Gene therapy for transplantation and inflammatory or thrombotic conditions (1997) (0)
Collaboration between in vivo responses to ld and sd determinants of the major histocompatibility complex. Abstr. (1976) (0)
Targets for cytotoxic lymphocytes. (1975) (0)
Method for the culture of leukocytes (1988) (0)
Relationships among Major Histocompatibility Systems (1971) (0)
7.6-01 Effect of FK 506 and CsA on lymphocyte activation by calcium ionophore (1989) (0)
Contents, Vol. 106, 1995 (2004) (0)
Comparison of DR beta 1 alleles from diabetic and normal individuals. (1987) (0)
Primed lympocyte typing (PLT) cloids detecting determinants other than HLA-Dw, DR, and SB (1982) (0)
Cellular basis of the proliferative response of human T cells in response to mouse xenoantigens (1989) (0)
Molecular Approaches to Selective Immunization. (1985) (0)
Role of H-2 LD and CD antigens in induction of in vitro unresponsiveness. (1977) (0)
Determination of DR beta 1 alleles of DR4/Dw subtypes by oligonucleotide probing. (1987) (0)
Human alloreactive T cell clones for PLT (1980) (0)
Physical association of murine leukemia virus envelope glycoprotein and mouse major histocompatibility antigens on leukemia cell surfaces and their recognition as target antigens by cytotoxic t-lymphocytes. Abstr. (1978) (0)
In vitro actions of antilymphocyte sera. (1970) (0)
PPARγ Regulates the Anti-Inflammatory Effects of Carbon Monoxide on Macrophages: A Gene Profiling Study. (2004) (0)
Elicitation of anti-leukemia cytotoxic responses. (1979) (0)
Factors in xenoantigen recognition. (1990) (0)
Lymphokine-activated Killer Cells Mechanism of Cultured Endothelial Injury Induced by Updated Version (2006) (0)
Fundamental Immunogenetics—Their Application to Histocompatibility12 (1972) (0)
Donor-recipient pairing for transplantation: present limitations and future objectives. (1970) (0)
T‐Cell Activation along an Alternative Pathway a (1988) (0)
Studies of histocompatibility using mixed leukocyte cultures (1972) (0)
Murine model for specificity of primed cells: Chairman summary of session IV of the second international conference on the primed lymphocyte☆ (1981) (0)
Book ReviewExperimental Skin Grafts and Transplantation Immunity: A recapitulation (1980) (0)
IN VIVO DEPLETION OF XENOREACTIVE NATURAL ANTIBODIES WITH AN ANTI‐μ MONOCLONAL ANTIBODY1,2 (1993) (0)
[Prolonged survival of xenogeneic grafts after organ culture]. (1976) (0)
Histocompatibility in man--genetic and practical considerations. (1969) (0)
Medawar Prize Lecture. The intimate relationship of the MHC with T lymphocytes. (1999) (0)
HLA and bone marrow transplantation. (1984) (0)
Heme oxygenase-1 and nitric oxide in the vasculature: in vivo balloon injury and in vitro VSMC studies in rats (2007) (0)
Role of murine leukemia virus and h-2 antigens on the surface of leukemia cells in immune cell mediated lysis. Abstr. (1978) (0)
On the problem of designating new loci inH-2 regions (1974) (0)
ALLOACTIVATION OF T LYMPHOCYTES: ALTERNATIVE PATHWAYS (1979) (0)
Cellular immunogenetics of HLA: quantitative crossmatches for LD and CD determinants. (1978) (0)
Evaluation of natural antibody levels relevant to xenotransplantation (1989) (0)
Long-Term Culture of IL-2-Generated Killer Cells with Antitumor Activity (2018) (0)
Molecular relationships between three high molecular weight murine t cell surface proteins. Abstr. (1980) (0)
H-2 I alloantigens and recall of memory cytotoxic responses. (1980) (0)
Lymphocyte-Defined Histocompatibility Differences as a Model for Tumor Antigens (1974) (0)
Procede de culture de leucocytes (1987) (0)
Genetic histocompatibility (HLA) associations with congenital craniofacial anomalies amenable to reconstructive surgery. (1978) (0)
Manipulation of immunologically reactive cell populations in vitro. Outline of an approach to specific immunotherapy of cancer. (1973) (0)
Carbon monoxide segnificantly reduces the apoptotic events associated with ischemia-reperfusion injury: observations in a renal pig-to-primate model (2004) (0)
Immunogenetic considerations in islet transplantation (1985) (0)
Cellular basis of allograft rejection. (1981) (0)
Toward an understanding of the basis of alloantigen recognition. (1989) (0)
Cellular Immunogenetics—Definition of HLA-D Region Encoded Antigens by T Lymphocyte Reactivities1 (1980) (0)
ROLE OF H-2 CD ANTIGENS IN SECONDARY RESPONSES (1977) (0)
Mechanisms of allograft and xenograft rejection: possibilities for the future (1995) (0)
H-2 b STRUCTURE ON MOUSE LEUKEMIA CELLS (1979) (0)
Lymphokine-activated Killer Activity in Long-Term Cultures with Anti-CD3 plus Interleukin 2: Identification and Isolation of Effector Subsets1 (2006) (0)
Genetic control of "in vitro" lymphocyte reactions. New concepts. (1973) (0)
Noncytotoxic T cell clones obtained from a human mixed leukocyte culture. (1990) (0)
Differences in the Recognition of MHC Class I Molecules by T-Cells and Antibodies (2019) (0)
HO-1 polimorphysm protect against chronic allograft nephropathy progression. (2007) (0)
Proliferating helper-cell (PHC) test: a possible addition to the armamentarium for histocompatibility testing. (1973) (0)
The major histocompatibility complex and its relationship to allergic disease. (1976) (0)
The Major Histocompatibility Complex and T-Lymphocyte Response (1987) (0)
The role of antigen presenting cells in secondary mixed lymphocyte hepatocyte cultures. (1991) (0)
Immunogenetic and cellular aspects of xenogeneic response (1989) (0)
Role of private and public H 2 alloantigens as targets for cell mediated cytotoxicity (1975) (0)

This paper list is powered by the following services:

Other Resources About Fritz Bach

en.wikipedia.org

What Schools Are Affiliated With Fritz Bach?

Fritz Bach is affiliated with the following schools: